BP11103 PTMC, Poly(trimethylene carbonate), Hydroxyl Terminated, IV ≤ 0.5 dl/g, Mw ≤ 20 kDa

PTMC, Poly(trimethylene carbonate), Hydroxyl Terminated, IV ≤ 0.5 dl/g, Mw ≤ 20 kDa Description

PTMC, Poly(trimethylene carbonate) with hydroxyl terminations presents controlled polymer chain ends that allow for subsequent functionalisation. The intrinsic viscosity of 0.5 dl/g reflects its moderate chain length, while a molecular weight of approximately 20 kDa provides a balance between processability and mechanical performance. This polymer exhibits predictable degradation behaviour suited for applications in biomedical devices and controlled drug delivery systems.

PTMC, Poly(trimethylene carbonate), Hydroxyl Terminated, IV ≤ 0.5 dl/g, Mw ≤ 20 kDa Applications

1.       Healthcare and Biomedical Devices
- Used as a scaffold material in tissue engineering to support cell growth by leveraging its controlled degradation profile.
- Applied as a matrix in controlled drug release systems to achieve steady therapeutic delivery due to its predictable breakdown.

2.       Industrial and Research Applications
- Serves as a component in specialty coatings for biocompatible surfaces, addressing contamination control and surface modification needs.
- Frequently used in experimental formulations to study polymer blending and modification, enhancing research outcomes by offering a consistent baseline material.

PTMC, Poly(trimethylene carbonate), Hydroxyl Terminated, IV ≤ 0.5 dl/g, Mw ≤ 20 kDa Packing

The product is packaged in moisture-barrier, sealed pouches to prevent contamination and degradation. It is stored under controlled temperature and low humidity conditions to maintain its physicochemical properties. Custom packing solutions are available, including inert gas purging and vacuum sealing, ensuring optimal preservation during transit and storage.

Additional Information

PTMC, Poly(trimethylene carbonate), is a biodegradable and biocompatible polymer widely studied in the field of biomedical materials. Known for its amorphous nature, it exhibits excellent biocompatibility and biodegradability, and remains in a rubbery state with inherent elasticity at body temperature. Its adjustable degradation profile and processability make it well-suited for applications such as soft tissue engineering, flexible implants, and controlled drug delivery systems. Understanding the relationship between its molecular weight and intrinsic viscosity is essential for tailoring its performance in specific biomedical and industrial contexts.

The presence of hydroxyl end groups provides reactive sites for further chemical modification, covalent conjugation, or chain extension, thereby enhancing its versatility in synthesising block copolymers, cross-linked networks, and functionalised biomaterials. This reactive functionality expands its utility in advanced manufacturing, formulation processes, and the development of customised polymeric systems. Ongoing research continues to refine processing techniques to enhance its performance, reliability, and reproducibility across a growing range of applications.

Regulatory Note: This material is intended for industrial and research applications. It is the customer's responsibility to ensure compliance with all relevant safety and regulatory standards in their intended use.